Paris, France and Camberley, UK – 26 February 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that through its molecular testing subsidiary, Primerdesign, it has reached a supply agreement with International Animal Rescue.
International Animal Rescue will use the Primerdesign genesig q16 real-time PCR instrument to test Orangutans, rescued in Indonesia, for a variety of diseases including plasmodium. Primerdesign will also undertake additional development work to tailor specific assays for testing Orangutans during recovery and before they are released into the wild.
The company has not revealed any details of the value of the supply agreement, but Novacyt CEO Graham Mullis said:
“We are delighted that International Animal Rescue has chosen to deploy our genesig q16 and genesig assays at its testing laboratory in Indonesia. The plight of Orangutans in the wild has been well documented recently and Novacyt are happy that our technology will be employed to assist the important effort to protect them.”
For International Animal Rescue a spokesperson said:
“We were delighted that Novacyt, through its subsidiary Primerdesign, has been able to supply us with instrumentation, test kits and support. Our staff in Indonesia are delighted with the genesig q16 and are seeing excellent results from the compact but powerful real-time PCR instrument.”
– End –
About International Animal Rescue
The head office of International Animal Rescue, comprising a small fundraising team, accounts department and supporter care, is based in the UK. From here the office works closely with teams in India, Indonesia, Armenia, Costa Rica and Malta in their efforts not only to save animals from suffering but to also rehabilitate and release them back into the wild and protect their natural habitats
UK Charity Registration Number: 1118277
United States Registered 501(c)(3) non-profit organization, Tax Id: 54-2044674
www.internationalanimalrescue.org
International Animal Rescue has no connection whatsoever with the group known as “The International Animal Rescue Foundation”.
About Novacyt Group
The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.
For more information please refer to the website: www.novacyt.com
